Atrial Fibrillation Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You (or a legal representative on your behalf) are willing and able to give consent to take part, following the rules of the institution and location
- You have already received a Micra AV2 device (a small, wireless pacemaker) or are planned to receive one as part of your normal medical care
- You have a history of occasional irregular heartbeat (called paroxysmal atrial fibrillation) and are having a Micra AV2 device implanted as part of your normal medical care
- You are between 18 and 85 years old and able to give your own consent for the procedure
- You are enrolled in the study within the required time window after receiving the treatment
- You speak English
Who may not be able to join:
- You are unlikely to be available for follow-up appointments after joining the trial
- Local laws in your area prevent you from participating
- You are already taking part in, or planning to join, another drug or device study that could affect the results of this trial
- You have a long-term or continuous form of irregular heartbeat (called persistent or chronic atrial fibrillation)
- You are currently a prisoner, or you have a cognitive impairment that would make it difficult to independently wear a heart monitor (Holter monitor) at home for research purposes
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Haisam Ismail, MD, Northwell Health
Phone: 516-600-1459
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
To evaluate the prevalence of atrial fibrillation in the Micra AV2 patients; To evaluate A4 amplitude trend changes during sinus rhythm and atrial fibrillation; To determine the ability of the Micra AV2 device to detect the presence and burden of atrial fibrillation
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.